Concomitant medications and risk of chemotherapy‐induced peripheral neuropathy

L Sánchez‐Barroso, M Apellaniz‐Ruiz… - The …, 2019 - academic.oup.com
Background Peripheral neuropathy is the dose‐limiting toxicity of many oncology drugs,
including paclitaxel. There is large interindividual variability in the neuropathy, and several …

[PDF][PDF] Concomitant Medications and Risk of Chemotherapy‐Induced Peripheral Neuropathy

L Sánchez‐Barroso, M Apellaniz‐Ruiz… - The …, 2019 - Wiley Online Library
Background Peripheral neuropathy is the dose‐limiting toxicity of many oncology drugs,
including paclitaxel. There is large interindividual variability in the neuropathy, and several …

Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy

L Sánchez Barroso, M Apellaniz Ruiz… - 2018 - docta.ucm.es
Background. Peripheral neuropathy is the dose-limiting toxicity of many oncology drugs,
including paclitaxel. There is large interindividual variability in the neuropathy, and several …

[引用][C] Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy

L Sánchez-Barroso, M Apellaniz-Ruiz… - …, 2019 - produccioncientifica.ucm.es

Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy.

L Sánchez-Barroso, M Apellaniz-Ruiz… - The …, 2018 - europepmc.org
Background Peripheral neuropathy is the dose-limiting toxicity of many oncology drugs,
including paclitaxel. There is large interindividual variability in the neuropathy, and several …

Concomitant Medications and Risk of Chemotherapy‐Induced Peripheral Neuropathy.

L Sánchez‐Barroso, M Apellaniz‐Ruiz… - …, 2019 - search.ebscohost.com
Background: Peripheral neuropathy is the dose‐limiting toxicity of many oncology drugs,
including paclitaxel. There is large interindividual variability in the neuropathy, and several …

[HTML][HTML] Concomitant Medications and Risk of Chemotherapy‐Induced Peripheral Neuropathy

L Sánchez‐Barroso, M Apellaniz‐Ruiz… - The …, 2019 - ncbi.nlm.nih.gov
Background. Peripheral neuropathy is the dose-limiting toxicity of many oncology drugs,
including paclitaxel. There is large interindividual variability in the neuropathy, and several …

Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy

L Sánchez-Barroso, M Apellaniz-Ruiz… - The …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Peripheral neuropathy is the dose-limiting toxicity of many oncology drugs,
including paclitaxel. There is large interindividual variability in the neuropathy, and several …